Pfizer Inc. (LON: 0Q1N)

Market Cap	119.68B
Revenue (ttm)	44.31B
Net Income (ttm)	3.17B
Shares Out	n/a
EPS (ttm)	0.56
PE Ratio	37.72
Forward PE	n/a
Dividend	1.32 (5.02%)
Ex-Dividend Date	Jan 24, 2025

Volume	62,296
Average Volume	122,120
Open	26.63
Previous Close	26.25
Day's Range	26.15 - 26.75
52-Week Range	19.48 - 25.24
Beta	0.62
RSI	45.75
Earnings Date	Feb 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and po...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 88,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q1N

Financial Performance

In 2023, Pfizer's revenue was $58.50 billion, a decrease of -41.70% compared to the previous year's $100.33 billion. Earnings were $2.12 billion, a decrease of -93.25%.

Financial numbers in USD